Amphetamine dependence.
Connell PH.
Proc R Soc Med. 1968 Feb;61(2):178-81.
Clinical management of psychostimulant withdrawal: review of the evidence.
Li MJ, Shoptaw SJ.
Addiction. 2023 Apr;118(4):750-762. doi: 10.1111/add.16093. Epub 2022 Dec 12.
The applicability of the dependence syndrome to amphetamine.
Topp L, Darke S.
Drug Alcohol Depend. 1997 Nov 25;48(2):113-8. doi: 10.1016/s0376-8716(97)00111-7.
Validation of the amphetamine dependence syndrome and the SAmDQ.
Topp L, Mattick RP.
Addiction. 1997 Feb;92(2):151-62.
Magnesium in drug dependences.
Nechifor M.
Magnes Res. 2008 Mar;21(1):5-15.
Overview of blood-brain barrier dysfunction in methamphetamine abuse.
Pang L, Wang Y.
Biomed Pharmacother. 2023 May;161:114478. doi: 10.1016/j.biopha.2023.114478. Epub 2023 Mar 14.
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
Jayaram-Lindström N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J.
Neuropsychopharmacology. 2008 Jul;33(8):1856-63. doi: 10.1038/sj.npp.1301572. Epub 2007 Oct 24.
Wide-QRS Complex Tachycardia.
Hanna EB, Johnson CJ, Glancy DL.
Am J Cardiol. 2018 Jan 15;121(2):275-276. doi: 10.1016/j.amjcard.2017.09.035. Epub 2017 Oct 19.
Thymoquinone: From Nigella sativa to a protective pharmacological compound in managing opioid dependence and amphetamine type stimulant issues.
Mohd Adnan LH, Abu Bakar NH, Simbak N, Mohamad N, Ismail R, Ahmad NZ, Mustafa NS, Md Fauzi NFA.
Iran J Basic Med Sci. 2020 Jul;23(7):849-852. doi: 10.22038/ijbms.2020.41678.9841.
[Amphetamine poisoning].
Robertsen A, Kowalczyk M, Gabrielsen AM, Jacobsen D.
Tidsskr Nor Laegeforen. 1998 Nov 20;118(28):4340-3.
